US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.560
  • +0.030+0.66%
Trading Jan 23 13:17 ET
494.05MMarket Cap-2.89P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
Net income from continuing operations
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
Depreciation and amortization
-38.55%110K
-52.89%114K
-47.33%128K
-6.49%807K
-37.28%143K
-18.26%179K
11.01%242K
22.73%243K
8.28%863K
20.00%228K
Deferred tax
----
----
----
--0
----
----
----
----
---367K
----
Other non cash items
-87.50%100K
650.00%1.5M
-89.29%300K
541.05%89.41M
535.18%85.61M
-52.94%800K
113.33%200K
450.00%2.8M
-531.30%-20.27M
-377.06%-19.67M
Change In working capital
-97.61%612K
116.21%759K
78.51%-1.94M
16.33%10.92M
-107.49%-994K
909.45%25.6M
-227.37%-4.68M
-104.82%-9.01M
885.69%9.39M
470.47%13.27M
-Change in receivables
79.44%6.69M
16.67%56K
190.67%68K
-110.75%-20K
-7,847.92%-3.72M
4,283.53%3.73M
-81.18%48K
62.87%-75K
33.81%186K
-57.52%48K
-Change in prepaid assets
----
-531.14%-1.18M
301.57%8.21M
-269.20%-4.86M
-207.78%-8.6M
118.56%1.43M
137.35%273K
333.87%2.04M
42.68%-1.32M
239.92%7.98M
-Change in payables and accrued expense
322.05%1.67M
156.82%2.84M
14.55%-9.38M
-177.30%-8.13M
63.87%8.6M
-116.96%-753K
-220.50%-5M
-230.47%-10.98M
995.63%10.52M
161.62%5.25M
-Change in other working capital
---715K
---962K
---833K
--23.93M
---1.02M
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
Investing cash flow
Cash flow from continuing investing activities
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
-34.75%16.83M
266.01%46.22M
179.42%7.55M
Net PPE purchase and sale
---23K
-250.00%-21K
68.15%-43K
90.76%-121K
--0
--0
106.06%14K
75.59%-135K
-116.36%-1.31M
-320.00%-441K
Net intangibles purchase and sale
----
--0
---833K
---35.81M
----
----
--0
--0
--0
----
Net investment purchase and sale
395.64%13.85M
836.63%5.07M
17.84%20M
-171.19%-33.84M
-762.16%-52.91M
-91.43%2.8M
96.46%-688K
-35.61%16.97M
259.17%47.53M
184.68%7.99M
Cash from discontinued investing activities
Investing cash flow
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
-34.75%16.83M
266.01%46.22M
179.42%7.55M
Financing cash flow
Cash flow from continuing financing activities
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
-55K
-63.35%26.71M
32.43%49K
Net common stock issuance
----
----
----
180.43%74.91M
--74.91M
--0
----
----
-63.28%26.71M
--0
Proceeds from stock option exercised by employees
----
----
----
-65.96%32K
--0
113.33%32K
----
----
-40.13%94K
32.43%49K
Net other financing activities
-30,340.00%-3.04M
18.18%-9K
-400.00%-275K
-300.98%-409K
---333K
---10K
---11K
---55K
-200.00%-102K
--0
Cash from discontinued financing activities
Financing cash flow
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
---55K
-63.35%26.71M
32.43%49K
Net cash flow
Beginning cash position
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-11.92%39.88M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
65.55%45.28M
-36.68%39.04M
Current changes in cash
-100.59%-146K
61.91%-4.96M
243.35%5.79M
-183.53%-15.31M
-2,854.30%-23.08M
214.54%24.82M
4.16%-13.01M
-627.39%-4.04M
-130.11%-5.4M
105.12%838K
End cash Position
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
-11.92%39.88M
Free cash flow
-146.01%-10.12M
18.64%-10.01M
33.49%-13.93M
29.67%-56.01M
-521.33%-44.75M
189.28%22M
41.07%-12.31M
22.14%-20.95M
-16.81%-79.63M
62.53%-7.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M21.01%-20.82M-15.92%-78.33M64.63%-6.76M
Net income from continuing operations -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M
Depreciation and amortization -38.55%110K-52.89%114K-47.33%128K-6.49%807K-37.28%143K-18.26%179K11.01%242K22.73%243K8.28%863K20.00%228K
Deferred tax --------------0-------------------367K----
Other non cash items -87.50%100K650.00%1.5M-89.29%300K541.05%89.41M535.18%85.61M-52.94%800K113.33%200K450.00%2.8M-531.30%-20.27M-377.06%-19.67M
Change In working capital -97.61%612K116.21%759K78.51%-1.94M16.33%10.92M-107.49%-994K909.45%25.6M-227.37%-4.68M-104.82%-9.01M885.69%9.39M470.47%13.27M
-Change in receivables 79.44%6.69M16.67%56K190.67%68K-110.75%-20K-7,847.92%-3.72M4,283.53%3.73M-81.18%48K62.87%-75K33.81%186K-57.52%48K
-Change in prepaid assets -----531.14%-1.18M301.57%8.21M-269.20%-4.86M-207.78%-8.6M118.56%1.43M137.35%273K333.87%2.04M42.68%-1.32M239.92%7.98M
-Change in payables and accrued expense 322.05%1.67M156.82%2.84M14.55%-9.38M-177.30%-8.13M63.87%8.6M-116.96%-753K-220.50%-5M-230.47%-10.98M995.63%10.52M161.62%5.25M
-Change in other working capital ---715K---962K---833K--23.93M---1.02M--------------------
Cash from discontinued investing activities
Operating cash flow -149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M21.01%-20.82M-15.92%-78.33M64.63%-6.76M
Investing cash flow
Cash flow from continuing investing activities 394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K-34.75%16.83M266.01%46.22M179.42%7.55M
Net PPE purchase and sale ---23K-250.00%-21K68.15%-43K90.76%-121K--0--0106.06%14K75.59%-135K-116.36%-1.31M-320.00%-441K
Net intangibles purchase and sale ------0---833K---35.81M----------0--0--0----
Net investment purchase and sale 395.64%13.85M836.63%5.07M17.84%20M-171.19%-33.84M-762.16%-52.91M-91.43%2.8M96.46%-688K-35.61%16.97M259.17%47.53M184.68%7.99M
Cash from discontinued investing activities
Investing cash flow 394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K-34.75%16.83M266.01%46.22M179.42%7.55M
Financing cash flow
Cash flow from continuing financing activities -13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K-55K-63.35%26.71M32.43%49K
Net common stock issuance ------------180.43%74.91M--74.91M--0---------63.28%26.71M--0
Proceeds from stock option exercised by employees -------------65.96%32K--0113.33%32K---------40.13%94K32.43%49K
Net other financing activities -30,340.00%-3.04M18.18%-9K-400.00%-275K-300.98%-409K---333K---10K---11K---55K-200.00%-102K--0
Cash from discontinued financing activities
Financing cash flow -13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K---55K-63.35%26.71M32.43%49K
Net cash flow
Beginning cash position 11.25%25.4M-15.30%30.36M-38.39%24.57M-11.92%39.88M22.06%47.65M-26.70%22.83M-19.86%35.84M-11.92%39.88M65.55%45.28M-36.68%39.04M
Current changes in cash -100.59%-146K61.91%-4.96M243.35%5.79M-183.53%-15.31M-2,854.30%-23.08M214.54%24.82M4.16%-13.01M-627.39%-4.04M-130.11%-5.4M105.12%838K
End cash Position -47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M-19.86%35.84M-11.92%39.88M-11.92%39.88M
Free cash flow -146.01%-10.12M18.64%-10.01M33.49%-13.93M29.67%-56.01M-521.33%-44.75M189.28%22M41.07%-12.31M22.14%-20.95M-16.81%-79.63M62.53%-7.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.21%
Sample Name
Sample Code
 +2.92%
Sample Name
Sample Code
 +2.90%
4
Amazon
AMZN
+2.17%
5
NVIDIA
NVDA
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.04%
Sample Name
Sample Code
 +8.84%
Sample Name
Sample Code
 +4.88%
4
KE Holdings
BEKE
+4.27%
5
H World Group
HTHT
+3.99%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -